US equities
|
NVDA
$240.42
▲+0.64%
SPCX
$172.30
▲+0.71%
MU
$1,057.88
▼-0.57%
MRVL
$287.74
▲+6.08%
AMD
$654.10
▲+3.54%
INTC
$114.62
▼-1.35%
AVGO
$378.91
▲+4.52%
TSLA
$380.20
▲+0.39%
NVDA
$240.42
▲+0.64%
SPCX
$172.30
▲+0.71%
MU
$1,057.88
▼-0.57%
MRVL
$287.74
▲+6.08%
AMD
$654.10
▲+3.54%
INTC
$114.62
▼-1.35%
AVGO
$378.91
▲+4.52%
TSLA
$380.20
▲+0.39%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about European Commission Approval
Recent news which mentions European Commission Approval
Rhythm Secures European Commission Marketing Authorization For Genetic Disease Candidate
September 06, 2022
Tickers
RYTM
Tags
General
Biotech
Benzinga
From
Benzinga